These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6102958)

  • 1. [Which beta receptor blockers should be used in hypertension?].
    Werning C
    Fortschr Med; 1980 Feb; 98(5):157-60. PubMed ID: 6102958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The editor's roundtable: revisiting the role of beta blockers in hypertension.
    Roberts WC; Black HR; Bakris GL; Mason RP; Giles TD; Sulkes DJ
    Am J Cardiol; 2007 Jul; 100(2):253-67. PubMed ID: 17631080
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical aspects of use of beta-blockers in the treatment of arterial hypertension].
    Widimský J
    Vnitr Lek; 1997 Apr; 43(4):221-5. PubMed ID: 9601840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta blockers in the treatment of arterial hypertension].
    Spinar J; Vítovec J
    Cas Lek Cesk; 1998 May; 137(9):278-81. PubMed ID: 9650357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we need a new classification of beta-blockers?
    Kendall MJ
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():27-9. PubMed ID: 1973460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Third generation beta blockers in the treatment of hypertension].
    Widimský J
    Vnitr Lek; 1992 May; 38(5):417-25. PubMed ID: 1354908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D; Papademetriou V
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers and hypertension: carbon copies or a real choice.
    Whipps RG; Fisher ML; Plotnick GD
    Compr Ther; 1984 Sep; 10(9):12-8. PubMed ID: 6149036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics.
    Wallin JD; Shah SV
    Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical application of beta-blockers with particular reference to hypertension].
    Kocijancić M
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():10-6. PubMed ID: 18193806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
    Kountz DS
    Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of beta1-beta2-selectivity and intrinsic sympathomimetic activity in beta-blockers, with particular reference to antihypertensive treatment.
    Imhof P
    Adv Clin Pharmacol; 1976; 11():26-32. PubMed ID: 25568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive treatment with beta receptor blockers and obstructive ventilatory disorder (author's transl)].
    Trauth HA
    MMW Munch Med Wochenschr; 1981 Jul; 123(27):1119-21. PubMed ID: 6114427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The rational selection of beta-blockers in the treatment of hypertension].
    Ter Arkh; 1999; 71(2):57-64. PubMed ID: 10222557
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
    Messerli FH; Bangalore S; Yao SS; Steinberg JS
    J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment.
    Burris JF
    Arch Intern Med; 1993 Sep; 153(18):2085-92. PubMed ID: 8104394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers and the patient with bronchial disease.
    Prichard J
    Ir Med J; 1986 Nov; 79(11):303-4. PubMed ID: 2879812
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical importance of lipid solubility in beta blockers.
    Neil-Dwyer G
    Aviat Space Environ Med; 1981 Nov; 52(11 Pt 2):S19-22. PubMed ID: 6118118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.